Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Health News Nevada.
Press releases published on April 11, 2025
New Mexico Donor Services Honors Donor Heroes, Families During Donate Life Month
GlobeNewswire
·
April 11, 2025
ALBUQUERQUE, N.M., April 11, 2025 (GLOBE NEWSWIRE) -- During the month of April, New Mexico Donor Services and Donate Life New Mexico celebrate Donate Life Month, paying tribute to everyone who said “yes” to giving the gift of life through organ, eye and …
Tennessee Donor Services Honors Donor Heroes, Families During Donate Life Month
GlobeNewswire
·
April 11, 2025
NASHVILLE, Tenn., April 11, 2025 (GLOBE NEWSWIRE) -- During the month of April, Tennessee Donor Services and Donate Life Tennessee celebrate Donate Life Month, paying tribute to everyone who said “yes” to giving the gift of life through organ, eye and …
Allegro demonstrates safety profile of osteoarthritis hydrogel in data presentation at World Congress on Osteoporosis
GlobeNewswire
·
April 11, 2025
Allegro’s microparticle hydrogel hydrocelin has the potential to be a first-in-class disease-modifying injectable treatment for osteoarthritis Preclinical study to be presented at WCO conference shows no pyrogenicity Pivotal clinical trial in …
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
GlobeNewswire
·
April 11, 2025
- The universal oxygen carrier delivery capabilities of BXT-25 can be monitored, broadening its applications to treat hypoxic diseases - Leading drug candidate ProLectin-M targets galectins in viral infections including bird flu like viruses BOSTON, …
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
GlobeNewswire
·
April 11, 2025
ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today announced that it …
BioCardia Initiates Patient Enrollment at Emory University School of Medicine for Ongoing CardiAMP HF II Pivotal Study
GlobeNewswire
·
April 11, 2025
CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction and Elevated Markers of Cardiac Stress Dr. Arshed Quyyumi, Professor of Medicine, Division of Cardiology, …
Scilex Holding Company Announces 1-for-35 Reverse Stock Split
GlobeNewswire
·
April 11, 2025
PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
GlobeNewswire
·
April 11, 2025
DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ: PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell …
Preliminary Results for the Year Ended 31 December 2024
GlobeNewswire
·
April 11, 2025
April 11, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company” or, together with its subsidiaries, the “Group”) Preliminary Results for the Year Ended 31 December 2024 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical …
US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6% CAGR | MarketsandMarkets™.
GlobeNewswire
·
April 11, 2025
Delray Beach, FL, April 11, 2025 (GLOBE NEWSWIRE) -- The US Radiotherapy Market is projected to reach US$2.49 billion by 2030 from US$3.25 billion in 2024, at a CAGR of 4.6%. The US radiotherapy market is growing due to ongoing technological innovations …
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
GlobeNewswire
·
April 11, 2025
HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic diseases …
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
GlobeNewswire
·
April 11, 2025
Conduit Pharmaceuticals files next generation cocrystal patent for VTAMA® (tapinarof) which the Company believes could be a superior asset with both inflammatory and autoimmune prospectives just as the drug approaches 2027 exclusivity expiration, …
Venus Concept Announces $1.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
April 11, 2025
TORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has entered into definitive agreements for the purchase and sale of 386, …
ImPact Biotech Announces New Data Presentations at AUA 2025 Highlighting Safety and Efficacy of Padeliporfin VTP
GlobeNewswire
·
April 11, 2025
- Company to present updated preliminary results from ENLIGHTED Phase 3 Study in LG UTUC - - Additional podium presentation to provide updates from long-term evaluation of Padeliporfin VTP in intermediate-risk prostate cancer - TEL AVIV, Israel, April 11, …
Alignment Healthcare to Announce First Quarter 2025 Financial Results and Host Conference Call Thursday, May 1, 2025
GlobeNewswire
·
April 11, 2025
ORANGE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2025 financial results on Thursday, May 1, 2025, after market close. Following the release, the company will host a conference call …
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 11, 2025
BRISBANE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement awards on April 2, 2025 to 18 new …
Crinetics Pharmaceuticals to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 11, 2025
SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report first quarter 2025 financial results on Thursday, May 8, 2025 after the market closes. Company management will host a …
Don’t just read the stats, change the future for seniors with your vote
GlobeNewswire
·
April 11, 2025
Toronto, Ontario, April 11, 2025 (GLOBE NEWSWIRE) -- In this federal election, your vote holds the power to change the future for seniors in Canada. Alarming statistics show that 1 in 3 seniors is at risk of social isolation, 1 in 10 experiences elder …
Palvella Therapeutics Announces QTORIN™ Rapamycin 3.9% Anhydrous Gel for the Treatment of Microcystic Lymphatic Malformations Featured in Oral Presentation by Amy Paller, M.S., M.D., Chair of Dermatology at Northwestern University’s Feinberg School of …
GlobeNewswire
·
April 11, 2025
Presentation highlighted the recent expansion of the Phase 3 SELVA trial to include children 3 to 5 years old Presentation reviewed clinically and statistically significant Phase 2 results and the design of the ongoing Phase 3 SELVA trial Top-line results …
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
GlobeNewswire
·
April 11, 2025
BOSTON, April 11, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track …